Liang, Kun

A two-pronged anti-leukemic agent based on a hyaluronic acid-green tea catechin conjugate for inducing targeted cell death and terminal differentiation. [electronic resource] - Biomaterials science Dec 2019 - 497-505 p. digital

Publication Type: Journal Article

2047-4849

10.1039/c9bm01146c doi


Animals
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Catechin--administration & dosage
Cell Death--drug effects
Cell Differentiation--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
HEK293 Cells
HL-60 Cells
Human Umbilical Vein Endothelial Cells
Humans
Hyaluronic Acid--administration & dosage
Leukemia, Myeloid, Acute--drug therapy
Male
Mice
Xenograft Model Antitumor Assays